Chemistry of Natural and Microbial Products Department, National Research Centre, Dokki, Giza, 12622, Egypt.
Medical Physiology Department, National Research Centre, Dokki, Giza, 12622, Egypt.
Antonie Van Leeuwenhoek. 2021 Mar;114(3):287-302. doi: 10.1007/s10482-021-01522-w. Epub 2021 Feb 9.
Microbial pathogens drive tumorigenesis in 20% of cancer cases, so the present study is aimed to evaluate the carcinogenic activities, sperm abnormalities and other dangerous effects of the subcutaneous injection of extracts obtained from various clinical Gram-negative bacteria derived from cancer patients using albino rats. We isolated, identified and extracted of their secondary metabolites of carbapenem resistant Gram-negative bacteria derived from cancer patients. Various methods have been used to determine hepatotoxicity, nephrotoxicity, tumorigenesis, inflammatory and sperm abnormalities in the albino rats injected with extracts. In comparison with the normal animals group, all extracts induced hepatotoxicity which was evidenced by the significant elevation in the activity of the serum alanine aminotransferase, aspartate aminotransferase, gamma-glutamyltransferase and alkaline phosphatase; also, nephrotoxicity that was indicated through the marked increase in the serum urea and creatinine levels; tumorigenesis was achieved from the sharp elevation in serum levels of alpha fetoprotein, carcinoembryonic antigen and lactate dehydrogenase values as tumor markers; as well as severe inflammatory characteristics were monitored from the marked raise of tumor necrosis factor alpha and interleukin-1beta. Furthermore, the proportion of micronuclei in polychromatic erythrocytes and sperm abnormalities were statistically significant in all groups compared to control group. Various kinds of head abnormalities and coiled tail were noted. Histopathological examination of hepatic tissue came in line with the biochemical and cytological findings. It could conclude that the extracts of Serratia sp. Esraa 1, Stenotrophomonas sp. Esraa 2, Acinetobacter sp. Esraa 3, Escherichia sp. Esraa 4 and Pseudomonas sp. Esraa 5 were able to initiate cytotoxicity and tumorigenesis in rats.
20%的癌症病例是由微生物病原体驱动的肿瘤发生,因此本研究旨在评估从癌症患者中分离出的各种临床革兰氏阴性菌提取的次级代谢产物对皮下注射的致癌活性、精子异常和其他危险影响,使用白化大鼠。我们从癌症患者中分离、鉴定并提取了耐碳青霉烯类的革兰氏阴性菌的次级代谢产物。使用各种方法来确定注射提取物的白化大鼠的肝毒性、肾毒性、肿瘤发生、炎症和精子异常。与正常动物组相比,所有提取物均诱导肝毒性,这表现为血清丙氨酸氨基转移酶、天冬氨酸氨基转移酶、γ-谷氨酰转移酶和碱性磷酸酶活性显著升高;此外,肾毒性表现为血清尿素和肌酐水平明显升高;肿瘤发生是通过血清α胎蛋白、癌胚抗原和乳酸脱氢酶值作为肿瘤标志物的急剧升高来实现的;以及严重的炎症特征是通过肿瘤坏死因子α和白细胞介素-1β的显著升高来监测到的。此外,与对照组相比,所有组的多色红细胞和精子异常中的微核比例均具有统计学意义。各种头部异常和卷曲的尾巴都被注意到。肝组织的组织病理学检查与生化和细胞学发现一致。可以得出结论,Esraa1 属的 Serratia sp.、Esraa2 属的 Stenotrophomonas sp.、Esraa3 属的 Acinetobacter sp.、Esraa4 属的 Escherichia sp.和 Esraa5 属的 Pseudomonas sp. 能够在大鼠中引发细胞毒性和肿瘤发生。